| (USD) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 25.12M | — |
| Operating expense | — | — |
| Net income | -120.86M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, CRNX returned +173.9% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +81.9% |
| 1 year | +173.9% |
| 5 years | +259.3% |
| All-time high | $84.69 (Aug 2026) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in CRNX would be worth today ›No. Crinetics Pharmaceuticals, Inc. has not paid a dividend in the past 12 months.
Crinetics Pharmaceuticals, Inc. stock trades on NASDAQ under the ticker symbol CRNX.
Crinetics Pharmaceuticals, Inc. is part of the Healthcare sector.
Crinetics Pharmaceuticals, Inc. has a market cap of 8.99B USD, based on the latest quote.
